Impact of Adjuvant Immune Checkpoint Inhibitors and Chemotherapy on Survival Outcomes in High‐Risk Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study
Satoshi Washino, Go Kaneko, Tomokazu Sazuka, Shoichi Nagamoto, Yuki Nakamura, Akinori Nakayama et al. Impact of Adjuvant Immune Checkpoint Inhibitors and Chemotherapy on Survival Outcomes in High‐Risk Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study. // International Journal of Urology. – 2026. – DOI: 10.1111/iju.70721. – URL: https://onlinelibrary.wiley.com/doi/10.1111/iju.70721?af=R
Satoshi Washino, Go Kaneko, Tomokazu Sazuka, Shoichi Nagamoto, Yuki Nakamura, Akinori Nakayama, Kohei Mito, Kosuke Kazashi, Kimitoshi Saito, Sumire Takeuchi, Akihiro Yano, & Tomoaki Miyagawa (2026). Impact of Adjuvant Immune Checkpoint Inhibitors and Chemotherapy on Survival Outcomes in High‐Risk Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study. International Journal of Urology. https://doi.org/10.1111/iju.70721
Satoshi Washino, et al. “Impact of Adjuvant Immune Checkpoint Inhibitors and Chemotherapy on Survival Outcomes in High‐Risk Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study.” International Journal of Urology, 2026. doi:10.1111/iju.70721.
@article{Washino2026,
title = {Impact of Adjuvant Immune Checkpoint Inhibitors and Chemotherapy on Survival Outcomes in High‐Risk Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study},
author = {Washino, Satoshi and Kaneko, Go and Sazuka, Tomokazu and Nagamoto, Shoichi and Nakamura, Yuki and Nakayama, Akinori and Mito, Kohei and Kazashi, Kosuke and Saito, Kimitoshi and Takeuchi, Sumire and Yano, Akihiro and Miyagawa, Tomoaki},
journal = {International Journal of Urology},
year = {2026},
doi = {10.1111/iju.70721},
url = {https://onlinelibrary.wiley.com/doi/10.1111/iju.70721?af=R}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...